A Davis Polk team led by partners Jim Rouhandeh, head of the firm’s Litigation Department, and Neal Potischman, head of the firm’s West Coast commercial litigation practice, received runner…
Davis Polk advised on 16 matters recognized by Turnarounds & Workouts as “Successful Restructurings of 2023.”The highlighted matters include:Air MethodsAvayaAzul S.A.Cineworld Group…
Davis Polk advised on multiple matters that were recognized at the 18th Annual M&A Advisor Turnaround Awards. The awards honor the year’s leading distressed M&A,…
On November 2, 2023, Davis Polk partners James Lin and Steve Wang will be among the speakers at the 10th annual BioCentury-BayHelix China Healthcare Summit. James and Steve will speak…
Davis Polk partner Jesse Solomon was quoted in the Capitol Forum on DOJ’s new self-disclosure safe harbor policy and its potential impact on health care M&A. Under the policy, federal…
Law360 has named four Davis Polk partners as 2023 MVPs:Margaret Tahyar – BankingJennifer Conway – BenefitsDavid Bauer – Life SciencesMarc Williams – Private EquityThe awards showcase…
Davis Polk was honored in connection with its role advising on ACELYRIN’s $621 million IPO, which was named an “Impact Deal of the Year – United States” at the 2023 LMG Life Sciences…
Davis Polk partner and Northern California co-head Alan Denenberg has been named to Daily Journal’s 2023 list of “Top Health Care Lawyers.” The award honors California’s top lawyers…
Seven Davis Polk transactions were recognized at International Financing Review’s 2022 IFR Awards. The awards honor the most important transactions across numerous sectors of the market, as…
On November 15, 2022, Davis Polk partners James Lin and Steve Wang will be among the speakers at BioCentury and BayHelix’s East-West BioPharma Summit. James and Steve will chair the “3rd…